Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With Posaconazole
PHASE2
SIR-POSA is a phase II trial of peripheral blood stem cell (PBSC) transplan...
24 Months Follow-up, Two Arm Study to Compare the Cardiovascular Profile in a Regimen With Everolimus + Mycophenolic Acid (MPA) Versus (vs.) a Regimen of CNI+MPA in Maintenance Renal Transplant Recipients
PHASE4
The objective of the study is to compare the cardiovascular profile of an e...
Pharmacokinetics and Pharmacodynamics of MPA in Stable Renal Transplant Patients
N/A
Study of the pharmacokinetic and pharmacodynamic variability of mycophenola...
Status
Unknown
Location
IRCCS Fondazione Policlinico San Matteo
Start Date
2006-06
Trial ID
NCT00780429
A Study Investigating the Renal Tolerability, Efficacy, and Safety of a CNI-free Versus a Standard Regimen in de Novo Heart Transplant (HTx) Recipients
PHASE4
This study will assess whether a calcineurin inhibitor (CNI)-free regimen w...
Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerous Inherited Disorders
PHASE2
This phase I/II trial studies the side effects of fludarabine phosphate, cy...